Printer Friendly

Otc Cough and Throat Remedy Industry Tied Largely to the Cold and Flu Period of the Year - Cough and Throat Products in the United States.

DUBLIN, Ireland -- Research and Markets ( has announced the addition of Cough and Throat Products in the United States to their offering.

As more Americans turn to self-medication for common ailments, it is not surprising that an increasing number of products are on the market to control or alleviate specific symptoms of cough, cold, and flu. But sales have been relatively flat in recent years, in part because these products are "single-symptom" solutions, as opposed to the "multi-symptom" products also available.

The OTC cough and throat remedy industry is also tied largely to the cold and flu period of the year, which usually runs from September through May. While an early flu season has the potential to translate to increased sales of OTC medications in the last quarter, it is not unusual for the flu season to taper off well before the end of the first quarter of the next year.

This report clearly identifies the principal external factors driving or curtailing growth in the cough and throat remedy market. Exclusive consumer research reveals the attitudes, needs and behavior of consumers, with analysis broken down both by demographic characteristics and by remedy type.

Six years of specific sales data provide a factual and impartial presentation of the market as a whole. This report also evaluates the performance of individual sectors in the market, and provides information about the major companies and brands. Using the SPSS forecasting package a five-year forecast of U.S. retail sales is created, revealing potential opportunities for growth and product development.

This report examines sales of OTC cough and throat remedies, specifically cough drops, cough medicine, and sore throat medicine. These products may or may not contain pharmacologically based ingredients (e.g. dextromethorphane or guiafenesin) and are designed specifically to soothe a sore throat and/or suppress/control coughing. They are not "cures" for the common cold, flu or other respiratory conditions; rather they provide relief from sore throat pain or control of a cough.

Products covered in this report include:

--Cough drops (lozenges)

--Single-symptom cough medicines (without analgesics or other active ingredients)

--Sore throat remedies

Excluded from this report:

--multi-symptom cough/cold/flu medications (with analgesics or other active ingredients)


--allergy medications

--products that may list "cough suppression" or "sore throat relief" as one of their benefits

This report contains US IRI InfoScan data.

Appendix: Trade Associations

Appendix: New Product Briefs

For more information visit
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 26, 2006
Previous Article:Medimmune Deals Briefing Provides a Comprehensive Summary of the Deals and Alliances Announced by the Company between 2001 and 2006.
Next Article:This Report Provides an Overview of the Retiree Health Care and Medicare Markets.

Related Articles
Run away from cold and flu season.
Healthy talk.
CDC issues tips, tools to prevent spread of flu.
The flu ... and you.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters